NEU 3.50% $14.05 neuren pharmaceuticals limited

Updated MST report - target of $3.68 a share, page-104

  1. 669 Posts.
    lightbulb Created with Sketch. 60
    once we get the confirmation of a successful phase 3, there would be no question the rest of world rights will be worth a lot. It would also further boost the optimism around 2591 which would be valued a lot more
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.